Roka Bioscience

About:

Roka Bioscience develops molecular assays and instrument systems for the food safety industry.

Website: http://www.rokabio.com

Twitter/X: rokabioscience

Top Investors: New Enterprise Associates, OrbiMed, Gen-Probe, Aisling Capital, TriplePoint Capital

Description:

Roka Bioscience is dedicated to developing rapid, highly accurate molecular assays and instrument systems for the Food Safety Industry. Its newly released Atlas System represents a new tier of molecular rapid pathogen testing, offering automation and technology that bring true walk-away convenience and workflow advantages to the laboratory. Roka is focused on creating novel testing solutions that help manufacturers mitigate risks, protect their brands, and meet the increasing testing demands now and for years to come.

Total Funding Amount:

$132M

Estimated Revenue Range:

$100M to $500M

Headquarters Location:

Warren, New Jersey, United States

Founded Date:

2009-01-01

Contact Email:

sroberts(AT)rokabio.com

Founders:

Paul G. Thomas

Number of Employees:

51-100

Last Funding Date:

2016-09-22

IPO Status:

Delisted

Industries:

© 2025 bioDAO.ai